Notably, completed and ongoing studies such as NCT06475586, NCT06937060, NCT06588296, and NCT06864026 are investigating semaglutide in patients with PsO and comorbid metabolic conditions, or tirzepatide (in PsA settings), assessing dermatologic outcomes and inflammatory or metabolic markers (78, 79)
Dietary fat restriction
A key property of Ipamorelin is its selective increase in GH levels without significant stimulation of other hormones , such as cortisol, prolactin, or somatostatin
Managing Side Effects in Research Settings Strategies that have proven effective in clinical trials for managing cagrilintide-related side effects include: Slower titration schedules Extending time between dose increases Meal timing adjustments Taking doses after meals rather than before Hydration optimization Maintaining adequate fluid intake Dietary modifications Smaller, more frequent meals
Discover how seasonal changes (from pollen to humidity) impact your skin microbiome and learn expert-backed skincare tips to keep your skin barrier healthy and glowing
